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Objectives: Percutaneous treatment of iliac artery occlusive disease has replaced open vascular econstruction for several 
indications. A balloon angioplasty with or without stent is not an option in the presence of infrainguinaI extension of 
the disease. The authors describe a technique that allows the construction of an aorto- or iliofemoral graft through a single 
groin incision, using a 4 mm PTFE graft, anchoring it proximally with a Palmaz stent and dilating both to the desired 
diameter. 
Design: Retrospective non-randomised study. 
Materials and Methods: Nineteen procedures were performed in 16 patients mainly because of ischaemic rest pain, 
often with trophic skin changes or minor gangrene. Three patients had a bilateral procedure. Twelve patients had one ot" 
more associated procedures: 10 distal bypasses, one thrombectomy, one reimplantation ofa distal bypass on the iliofemoraI 
graft, one contralateral profundaplasty and two stents of the contralateral common iliac artery. 
Results: Two patients died, one of small bowel ischaemia nd the other of a myocardial infarction. During the mean 
follow-up of 8.8 months, two graft thromboses occurred. In another patient bilateral stenting of a residual stenosis was 
necessary. 
Conclusions: Our experience shows that the reported technique is feasible. Whether the procedure is truly "less invasive" 
and the long-term results acceptable r mains to be shown. 
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Introduction 
In recent years aorto-bifemoral (ABF) and iliofemoral 
(IF) grafting have been replaced by percutaneous trans- 
luminal angioplasty (PTA) for short, non-complicated 
lesions and by stenting for restenoses, eccentric plaque, 
recoil, long segment disease, dissection and occlusions. 
However, both proximal and distal extension of the 
atherosclerotic disease can limit the application of 
these percutaneous techniques. In the former situation 
an ABF might still be the procedure of choice. If distal 
extension is the only limiting factor, stented PTFE 
grafts that are introduced transfemorally can avoid an 
abdominal approach. 1 We report our experience with 
the use of a 4 mm PTFE graft in combination with a 
balloon expandable stent. 
Materials and Methods 
From February 1995 to February 1996 there were 21 
attempts to perform a transfemoral iliofemoral bypass. 
* Address for correspondence: Dr. H. Lacroix, Department of Vas- 
cular Surgery, UZ Gasthuisberg, Herestraat 49, 3000 Herestraat, 
Belgium. 
In two cases the iliac artery could not be recanalised 
and a standard femorofemoral cross-over bypass was 
performed. The remaining 19 procedures were per- 
formed in 16 patients (11 male, five female), with a 
mean age of 71 years (range 47-88). Five patients were 
current smokers, 11 had atherosclerotic heart disease, 
12 were on antihypertensive drug therapy, and one 
patient had diabetes mellitus. Three patients had a 
serum creatinine of more than 1.5mg/dl.  The in- 
dications for surgery were incapacitating claudication 
(n = 5), ischaemic rest pain (n = 7) and rest pain with 
trophic skin changes or gangrene (n -- 7). The extension 
of the atherosclerotic lesions are described in Table 1. 
Surgical technique 
Following preparation of the patient for a possible 
open iliofemoral graft and other associated vascular 
reconstructions, the femoral bifurcation was exposed. 
The common femoral artery was punctured with an 
18 G angiographic needle. Using portable C-arm 
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Table 1. Description of lesions. 
Normal Stenosed Occluded 
Common iliac artery 12 5 2 
External iliac artery - -  11 8 
Common femoral artery 7 5 7 
Superficial femoral artery 5 4 10 
fluoroscopic imaging, the diseased segment was pre- 
dilated with a 10mm PTA balloon after being re- 
canalised with a hydrophilic guide wire (Terumo, 
Tokyo, Japan) and a 14F sheath was introduced. For 
an occluded external i iac artery, contralateral puncture 
and antegrade recanalisation might be expected to 
prevent an internal iliac artery occlusion due to up- 
ward dissection, and this was done in two patients. A
4 mm PTFE graft (Impra) was sutured to a Palmaz 
balloon expandable stent (P394 Johnson and Johnson, 
U.S.A.) with four stitches 5/0 polypropylene (Ethicon, 
Edinburgh, U.K.), leaving one-third of the stent outside 
the graft. This tented graft was mounted on a PTA 
balloon and introduced through the sheath. Following 
positioning of the proximal end, the stent and the 
entire graft were dilated with a 10 or 12 mm balloon. 
To avoid angulation of the graft, the common femoral 
artery was transected at the puncture site. Finally, the 
graft was sutured to the outflow tract, either the 
deep femoral artery or a distal bypass (Fig. 1). The 
anastomosis was made with 7/0 or 8/0 PTFE (Gore), 
to avoid large stitch-holes in a thin PTFE graft. 
All but one procedure were performed under gen- 
eral anaesthesia. A unilateral bypass was performed 
in 13 patients, and three patients were operated on 
both sides during the same anaesthesia. The proximal 
stent was placed in the external iliac artery in three 
cases, and in the common iliac in 14. One patient had 
an aorto-bifemoral graft constructed with both stents 
placed at the aortic bifurcation. Twelve patients had 
one or more associated procedures: 10 distal bypasses, 
one thrombectomy, one reimplantation of a distal by- 
pass on the iliofemoral graft, one contralateral pro- 
fundaplasty and two stents of the contralateral 
common iliac artery. On average, 4 units of blood were 
transfused (range 0-8 units) and the mean procedure 
duration was 5 h (range 2.6-7 h). When no associated 
procedure was done the procedure duration ranged 
from 2.6 to 3.7 h. 
Follow-up and statistics 
Patients were examined at the outpatient clinic at 
regular intervals (1 month, 3 months, 6 months and 1 
year), at which time a duplex scan was performed. 
The study design was retrospective. Primary and 
secondary patencies were calculated using the Kaplan- 
Meier method. The 95% confidence limits (CL) are 
given in brackets. 
Results 
Two patients died in the postoperative period (2/16). 
The causes of death were small bowel ischaemia of 
Fig. 1. Illustration of a typical case with extensive atherosclerotic disease, excluding percutaneous treatment as an option. 
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unknown aetiology, and myocardial infarction. Three 
patients had a general complication: a stroke, a bleed- 
ing episode of a gastric ulcer, and one episode of 
angina. In five out of 19 procedures a local com- 
plication occurred. One patient had an infection of 
the groin incision treated by i.v. antibiotics, wound 
debridement and a rectus femoris muscle flap. In one 
patient hrombosis of the contralateral femoral artery 
occurred following puncture at that side. A throm- 
bectomy was successfully performed uring the same 
anaesthesia. In the patient with the aorto-bifemoral 
graft the postoperative arteriogram showed a residual 
stenosis in the middle of each graft, probably caused 
by extrinisic compression or recoil. A few months 
later these were treated by percutaneous transluminal 
balloon angioplasty (PTA) and stenting. Of the nine 
patent internal iliac arteries at risk preoperatively, 
one occluded during the procedure. This occlusion 
remained asymptomatic. 
The mean hospitalisation of the survivors (14) was 
15 days (range 3-57 days). Seven were discharged 
within 10 days of the procedure. Five patients were 
continued on coumadine derivatives, one patient had 
no medication, because of an active gastric ulcer, and 
the remainder continued with anti-platelet agents. 
The mean follow-up of the 14 survivors was 8.8 
months (range 2-13 months). For eight patients there 
was more than 12 months' follow-up. Two patients 
died during the third postoperative month: the first 
because of heart failure, and the second from sudden 
death of unknown cause. Survival was 88% (CL 71- 
104%) at 1 month and 75% (CL 54-96%) at 1 year. 
During the second month one graft occlusion occurred. 
The patient was in heart failure at the time and he 
subsequently died, as already mentioned. A second 
graft occluded at 11 months. A thrombectomy with 
associated distal bypass was performed. Except for the 
patient with a residual stenosis on both aortofemoral 
grafts, no other stenoses or occlusions occurred. So 
the primary patency of the 19 reconstructions was 
100% at i month and 70% (CL 44-95%) at 1 year. The 
secondary patency was, respectively, 100% and 93% 
(CL 81-106%). 
Discussion 
PTA is generally accepted as the treatment of choice 
for a short iliac stenosis. Although the long-term result 
of stenting of complex lesions is awaited, the procedure 
is certainly less invasive compared to an open vascular 
reconstruction or bypass. Sometimes the athero- 
sclerotic disease xtends down to, or even beyond, the 
level of the femoral bifurcation. In that case surgery 
is the only option besides a conservative approach. An 
anatomical reconstruction such as an aorti-bifemoral 
or iliofemoral graft is considered by most vascular 
surgeons as the treatment of choice, with excellent 
long-term results. However, the procedure is more 
invasive and is associated with a higher morbidity 
and longer hospital stay. Furthermore, suturing a graft 
to a sometimes very calcified aorta or iliac artery can 
be very difficult and hazardous. An extra-anatomical 
reconstruction, be it an axillofemoral or a femoro- 
femoral cross-over bypass, might be less invasive, but 
leads to inferior results in the long run. 2-5 
In search of a procedure that is less invasive with 
good long-term results, a few vascular surgeons have 
explored the possibilities of limiting the surgical ap- 
proach to a single groin incision. 
Both iliofemoral and femoropopliteal bypasses 
through a single groin incision have been proven to 
be feasible in animal and human cadaver studies 6as 
well as in clinical circumstances ~'7using a 6 mm PTFE 
graft and a Palmaz stent for proximal anchoring. Al- 
though the preliminary results are comparable to the 
results in this report, we believe that a 6 mm graft in 
aortofemoral or iliofemoral position constitutes some- 
what of a mismatch to the diameter of the native 
vessels. However, Bergeron has shown that PTFE 
grafts can be radially dilated to 400%, or five times 
the initial diameter, before rupture. 8 Therefore, we 
have chosen to balloon dilate a small calibre PTFE 
graft to the desired diameter after introduction. 
The retrograde iliofemoral endarterectomy faci- 
litated by balloon angioplasty has been proposed as 
an alternative procedure. 9 The fact that a prosthesis i  
no longer necessary would be a clear advantage if the 
procedure is feasible and the results acceptable. Both 
conditions seemed to be fulfilled in the report of 
Queral, with three failures on a total of 36 cases and 
primary patency rate of 80% at 3 and 5 years. However, 
many patients were not considered as candidates for 
this procedure. A tortuous, extremely calcified or oc- 
cluded iliac artery was considered a contraindication. 
The technique described in the present report is 
a feasible and valuable procedure, providing good 
arterial inflow with a good match between artery and 
graft diameter and avoiding a surgical approach to 
the iliac arteries. Whether this procedure is truly less 
invasive compared to the open technique can only 
be determined by a prospective, randomised trial. 
Although the initial results are encouraging, long-term 
graft behaviour and results have to be awaited. 
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